EEG and Neurology Testing Insurance Denied? How to Appeal

Neurological diagnostic testing — including electroencephalograms (EEG), nerve conduction studies (NCS), electromyography (EMG), neuropsychological testing, and brain MRI — provides essential information for diagnosing and managing serious conditions including epilepsy, multiple sclerosis, dementia, peripheral neuropathy, and autoimmune encephalopathy. When insurers deny this testing, they are not just refusing to pay for a test — they are delaying diagnosis and deferring treatment. These denials are both clinically problematic and legally challengeable.

Why Insurers Deny Neurology Testing

"Not medically necessary" based on insufficient symptom documentation. The most common denial reason. Insurers require that symptoms documented in the medical record clearly indicate the specific test is necessary. An EEG (CPT 95816, 95819) may be denied if the clinical notes do not explicitly document suspected seizure activity, unexplained episodes of altered consciousness, or other EEG-specific indications per AAN guidelines.

Frequency or repeat testing restrictions. Insurers may deny repeat EEGs for patients with known epilepsy who are experiencing breakthrough seizures, or repeat NCS/EMG for patients with worsening neuropathy, citing internal frequency guidelines that may conflict with clinical practice. The American Academy of Neurology (AAN) clinical guidelines for epilepsy and neuropathy management support repeat testing when the clinical situation has changed.

Neuropsychological testing volume restrictions. Comprehensive neuropsychological testing batteries — used to evaluate cognitive function in dementia workup, TBI assessment, and multiple sclerosis — may be denied as excessive in scope, or denied when the insurer argues a shorter cognitive screening is sufficient. The specific battery ordered should be matched to the clinical question, and the neuropsychologist's documentation should explain why a comprehensive battery (rather than a brief screen) is necessary.

Ambulatory or video-EEG denied as not medically necessary. Ambulatory EEG and prolonged video-EEG monitoring (CPT 95951, 95961) are essential for characterizing epilepsy type, identifying seizure semiology, and planning surgical evaluation for medication-refractory epilepsy. Insurers may deny these more intensive studies, arguing that a routine EEG is sufficient even when the clinical question requires extended or video monitoring.

Prior Authorization Denied: How to Appeal" class="auto-link">Prior authorization not obtained. Neurology testing generally requires prior authorization, particularly for neuropsychological testing batteries and video-EEG. Claims submitted without PA, or where the actual testing exceeded the authorized scope, are denied. Retroactive authorization requests require strong clinical documentation.

How to Appeal a Neurology Testing Denial

Step 1: Identify the Specific Denial Reason and Clinical Criteria Applied

Obtain the complete denial letter and the specific clinical criteria the insurer applied. Under ERISA 29 U.S.C. § 1133 for employer-sponsored plans, the insurer must disclose the criteria used. ACA Section 2719 (42 U.S.C. § 300gg-19) provides internal and external appeal rights. Identify precisely what the insurer is claiming is missing from the clinical record — this tells you exactly what documentation your appeal must provide.

Step 2: Obtain Your Neurologist's Detailed Clinical Letter

Your treating neurologist or neuropsychologist should document: the specific diagnosis or clinical question being evaluated; the ICD-10 diagnosis or symptom code (G40.x for epilepsy, G35 for multiple sclerosis, G20 for Parkinson's disease, G30.x for Alzheimer's disease, G62.9 for neuropathy, R41.3 for other amnesia, or the applicable code for your condition); why the specific test ordered is necessary for this clinical question; what prior testing has been done and why it is insufficient; and the AAN or specialty society clinical guideline supporting the test for this indication.

Step 3: Cite American Academy of Neurology Guidelines

The AAN publishes evidence-based clinical practice guidelines for epilepsy, dementia, multiple sclerosis, neuropathy, and other neurological conditions that explicitly address when specific diagnostic tests are indicated. For epilepsy, the AAN and American Epilepsy Society (AES) publish guidelines supporting EEG in the evaluation of first unprovoked seizure, characterization of seizure type, and pre-surgical evaluation. For peripheral neuropathy, AAN guidelines support NCS/EMG in the diagnostic workup. Cite the specific AAN guideline recommendation applicable to your clinical situation.

Step 4: Document the Downstream Consequences of Denial

Make this argument explicitly in your appeal: denying the diagnostic test does not eliminate the need for a diagnosis — it delays it and may result in more costly or invasive interventions. For epilepsy, a denied EEG means medications may be prescribed without a confirmed epilepsy diagnosis, increasing both clinical risk and future healthcare costs. For autoimmune encephalopathy, a denied EEG and CSF workup means potentially reversible disease goes untreated. Quantify the clinical and economic cost of delayed diagnosis.

Step 5: File the Internal Appeal with Full Documentation

Submit within 180 days of denial. Include the neurologist's letter, ICD-10 codes, AAN guideline excerpts, prior test results showing the limitations of existing data, and a direct rebuttal of each stated denial reason. Request that the appeal be reviewed by a board-certified neurologist — not a general internist or non-specialist reviewer.

Step 6: Escalate to External Independent Review: Complete Guide" class="auto-link">External Review and State Commissioner

If the internal appeal fails, file for independent external review, specifying that the reviewer must have neurology expertise. Independently file a complaint with your state insurance commissioner if you believe the denial reflects a systematic pattern of denying basic neurological diagnostic testing. Regulatory complaints create a formal record and may prompt broader enforcement action.

What to Include in Your Appeal

• Denial letter with the specific clinical criteria applied and the CPT code(s) at issue (EEG: 95816, 95819; video-EEG: 95951, 95961; NCS: 95907–95913; EMG: 95860–95872; neuropsychological testing: 96116, 96132–96133)
• Neurologist's or neuropsychologist's letter of medical necessity with ICD-10 diagnosis or symptom code and specific clinical rationale for the test ordered
• AAN clinical practice guideline excerpts matching your neurological condition and the specific test denied
• Prior test results and clinical notes documenting the clinical question that the denied test is needed to answer
• Documentation of the clinical risks and consequences of delayed or denied neurological diagnosis
• Records of any prior testing performed and its limitations in answering the specific clinical question

Fight Back With ClaimBack

When neurology testing is denied, the consequence is delayed diagnosis, delayed treatment authorization, and delayed care — with real clinical harm for conditions like epilepsy, MS, and autoimmune encephalopathy. A well-documented appeal citing AAN guidelines and the specific clinical indication is highly effective in overturning these denials. ClaimBack generates a professional appeal letter in 3 minutes, building the neurology testing appeal with the documentation structure and guideline citations that get results.

Start your free claim analysis →

Free analysis · No credit card required · Takes 3 minutes

Related Reading

• How to Write an Insurance Appeal Letter
• What Is Medical Necessity?
• Internal vs External Insurance Appeal